Werewolf Therapeutics, Inc.
Recent Filings
All 368 filings →| Form | Description | Date |
|---|---|---|
| 10-K | 10-K | Mar 27, 2026 |
| 8-K | 8-K | Mar 27, 2026 |
| 3 | FORM 3 | Mar 13, 2026 |
| 8-K | 8-K | Feb 24, 2026 |
| 8-K | 8-K | Feb 13, 2026 |
| SCHEDULE 13G/A | — | Feb 11, 2026 |
| 8-K | 8-K | Feb 6, 2026 |
| 4 | — | Jan 20, 2026 |
| SCHEDULE 13D/A | — | Jan 16, 2026 |
| 4 | — | Jan 15, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| EVNIN LUKE | — | Sale | 59,307 @ $0.69 | 2,782,650 | Dec 23, 2025 |
| EVNIN LUKE | — | Sale | 9,983 @ $1.14 | 2,841,957 | Dec 15, 2025 |
| EVNIN LUKE | — | Sale | 17,858 @ $1.08 | 2,890,128 | Dec 11, 2025 |
| EVNIN LUKE | — | Sale | 34,041 @ $0.99 | 3,017,669 | Dec 9, 2025 |
| MPM BioVentures 2014 (B), L.P. | — | Sale | 59,277 @ $0.89 | 4,924,566 | Dec 3, 2025 |
| MPM BioImpact LLC | — | Sale | 83,230 @ $0.97 | 4,784,111 | Dec 3, 2025 |
| EVNIN LUKE | — | Sale | 53,416 @ $0.97 | 3,068,278 | Dec 2, 2025 |
| EVNIN LUKE | — | Sale | 38,978 @ $0.98 | 3,248,573 | Dec 1, 2025 |
| MPM Asset Management Investors BV2014 LLC | — | Sale | 60,733 @ $0.98 | 5,065,037 | Dec 1, 2025 |
| UBS Oncology Impact Fund L.P. | — | Sale | 60,733 @ $0.98 | 5,065,037 | Nov 28, 2025 |